Therapeutic Drugs in Cancer
The first study examined the interaction between low doses of the multi-kinase inhibitor sorafenib and the histone deacetylase inhibitor vorinostat in colon cancer cells. Sorafenib and vorinostat synergized to kill HCT116 and SW480 cells. In SW480 cells, sorafenib+vorinostat toxicity correlated with...
Main Author: | Walker, Teneille |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2009
|
Subjects: | |
Online Access: | http://scholarscompass.vcu.edu/etd/1722 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=2721&context=etd |
Similar Items
-
Therapeutic drugs in cancer and resistance.
by: Martin, Aditi Pandya
Published: (2009) -
CELL DEATH AND GROWTH ARREST PATHWAYS MEDIATING THE ACTIONS OF STILBENE 5C IN HCT-116 COLON CANCER CELLS
by: Alotaibi, Moureq
Published: (2012) -
THE IMPACT OF ADOLESCENT NICOTINE EXPOSURE ON DRUG DEPENDENCE IN ADULTHOOD
by: Alajaji, Mai
Published: (2010) -
Development of Natural Cyclic Peptide Inhibitors of XRCC4/XLF Interaction for Radio-Sensitization of Breast Tumor Cells
by: AL, MOHAINI MOHAMMED
Published: (2012) -
Functional Characterization of CRIP1a Knockout Mice
by: Jacob, Joanna
Published: (2013)